igeahub.com
FDA Approved Keytruda of Merck for Hodgkin lymphoma - IgeaHub
March 14, 2017 Merck has received another FDA approval for Keytruda, and this time for classical Hodgkin lymphoma, marking the PD-1 blocker’s first